Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib with Pemetrexed and Carboplatin in Advanced NSCLC
NCT00473486Phase 2Terminated
- Sponsor
- Universitätsklinikum Münster
- Start
- May 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in non-small cell lung cancer (NSCLC), sponsored by Universitätsklinikum Münster. Started May 2007; status: terminated.
02
Drugs
sorafenib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00473486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00473486.